• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Method for the performance of a mutagenicity test so that a cell population is subjected to a mutagen. As a result of this, a part of the population mutates, whereat the originally uniform cell population is differentiated into sub-populations. The variation of turbidity caused by the increase in the density of the differentiated cell populations is measured as a change in optical density by means of a photometer measuring vertically at a certain wavelength, and the quantity of cells in the sub-populations is determined as optical density. The absorbance values are measured in accordance with a pre-programmed time share system and a growth curve is formed out of the values as a function of time.
    公开号:SU1442090A3
    申请号:SU843715344
    申请日:1984-03-11
    公开日:1988-11-30
    发明作者:Фалк Кай
    申请人:Лабсистемз Ой (Фирма)；
    IPC主号:
    专利说明:

    3U42090
    quantitative change
    l hl
    growth of the cell population.
    The initially homogeneous exotrophic cell population can be divided at the genetic level, using the mutagen effect on exotrophic and prototrophic subgroups. Using a photometer, we observed the growth of these populations, which can be in one common cell, can be determined from the curve of population growth versus time, the sample's mutagenicity, toxicity, the nature of toxicity (bacteriostatic, bactericidal), decomposition of toxic compounds and growth factors if present in the sample. It is not necessary to work with the sample itself or experimental organisms.
    In order to establish the frequency of spontaneous mutations (the so-called base), it is necessary to compare the sample with other similar but not containing mutagens. The efficiency of the method is assessed using an appropriate sample containing known mutagens. Depending on the sample under study, several parallel, series and / or its dilutions are carried out,
    In the microbiological mutagenicity test, it is possible to use genetically precisely determined amino acid exotrophic labeled bacterial strains. Change in genotype,. caused by a mutation, they are detected as phenotypically altered needs for growth factors, so that the cells that the mutation has been directed to become independent of the influence of the amino acid growth factor.
    In the proposed method, an initially genetically homogeneous population of bacteria is exposed to mutagens, as a result of which a part of the population mutates from scrophores into prototrophs. An increase in turbidity in the subgroup thus obtained can be detected spectrometrically even at a subminimum level — not with a vertical FP-901 photometer, since changes in fluid volume and the deposition of bacterial cells do not affect the result of absorbance measurement.
    0
    five
    0
    five
    0
    five
    0
    five
    0
    five
    When all the amino acid growth factors were consumed, only cells containing the mutation were able to grow. The larger the population of mutant cells introduced at the beginning of the experiment, the faster they reach the spectrometrically determined density. The time from the start of the experiment to the time of measurement is inversely proportional to the mutagenic activity of this sample. The curve of the dependence of population growth on the initial absorptive capacity (the so-called growth curve) gives, in addition to information about the mutagenicity of the sample, also information about the growth factors contained in it, if any.
    1-3, various growth curves are shown (levels of absorption as a function of time on a logarithmic scale).
    The method is carried out as follows.
    The test uses E.coli WP2 (trp) and Salmonella typhimurium (his) or any other convenient amino acid exotrophic labeled strains. Growth and differentiation of cell populations are recorded using a vertical FP-901 spectrophotometer, with the change, fluid level and cell deposition not affecting the result of absorbance measurement. .
    The study and cell growth takes place in a thermostat in a cuvette set with 1 cuvette per sample, on Davis-Mingioii, Vogel-bonner or any other suitable subminimal liquid medium. The initial size of the cell population, it is placed in an FP-901 spectrophotometer in its own vessel, in which an increase in the number of cells causes a change in the absorbance of dA oj / IO cl. Current 0.001. At the stage of mutagenization, cells are exotrophically divided by the action of growth factor 5 times. After the growth factor has been consumed, the growth of exotrophic cells ends, and the cells, which are mutated into prototrophs, continue to grow. The higher the percentage of prototrophic cells in the entire population, the faster they reach a density that can be measured.
    The time elapsed by the time of measurement is used as a quantitative
    assessment of mutagenic activity in
    with non-toxic samples. Depending on the growth rate of the experimental organisms, the duration of the study varies, in the case of E. coli and S. typhimurium it does not exceed 24 hours.
    The curve obtained as a function of the magnitude of the absorption capacity is an illustration of diakustic growth.
    In Fig. 1, curve 1 corresponds to an immediate growth (non-toxicity, a survival rate of 100%), curve 2 corresponds to a survival rate of 80%, curve 3 - a degree of 50%, and curve 4 - a degree of survival of 20%. The percentage of dead cells can be calculated by the formula
    one
    2t7gt
    where n is the percentage in the initial population (1.000); the time elapsed to the moment when the zero level is exceeded gt wen (td, t is the growth time
    tp; (t, - t,
    In Fig. 2, curve 5 shows slow growth, curve 6 shows bactericidal activity (bactericidal rate of 50%), curves 7 and 8 show non-destructive bacterostatic substances, and curve 9 shows destructible bacteriostatic substances.
    On fig. 1, - 1D (a) shows the calculation of the growth factor.
    The following factors can be determined from the two-phase growth curve:
    1) the toxicity of the drug ic of the initial moment of the first logarithmic stage (figure 1); .
    2) the nature of the sample toxicity (bactericidal effect, bacteriostaticity, and destructive bacteriostaticity) by the type of growth curve of the first logarithmic stage;
    3) the growth rate of unmutated cells by the angle (K,), which forms the growth curve of the first logarithmic stage (fig.Z);
    4) the growth rate of mutants in terms of the angle (K.) of the second logarithmic stage (FIG.
    5) the growth factors, if any, present in the preparation, by the magnitude of the absorption at the plateau stage 1.
    1442090 case
    Number additionally received
    growth factor mutants are determined by the formula
    Fp xgxr
    where Fp is the surplus of mutants after the V consumption of the surplus factors
    growth;
    g is the number of cell generations; g is the number of mutants in one generation multiplied (x) by the size of the population (S),
    I V e. The original level of balance i
    S. D, - DO S,,. 1, final residue level
    - Dj - DO
    g - the number of cell generations - D, - DO / D k, / t5 -t -kyt5-t;
    6) drug mutagenicity along the length of the plateau 1 curve (fig.Z);
    7) the number of mutants at the time of 25
    t o by extrapolating the ratio
    no degrees of growth in the first and second logarithmic stages;
    D is the detected size of the final population; but
    k, / t5-t | - the number of divisions in the first logarithmic stage;
    b
     -C5 is the number of divisions at the stages of the plateau 1 and the second logarithmic stage;
    X is the number of mutants at time point to;
    D
    Example. Conducting the test. Cultivation medium 965 µl Bacterial cells 5 µl Sample 10 µl
    Enzyme activating system S-9 20 µl (if required).
    These components are placed in a 1 ml cuvette, mixed with a vibrator for 15 s, placed in a thermostat at + 37 ° C, kept in a FP-901 spectrophotometer at a wavelength of 405 nm, then incubated for 20-24 hours, absorbed during this time the ability of the sample to
    71
    It is measured at a wavelength of 403 nm in accordance with the approved mode — my work.
    Based on the degree of absorption, the growth curve is constructed as a function of time by which the drug mutagenicity and some other parameters can be obtained.
    Nephelometric bacterium test. “Avid mutagenicity is convenient for all types of mutagenicity research, it is necessary to establish in the cohort whether the sample under study can interact with DNA with the formation of mutations.
    442090
    Formula
    the invention
    The method for determining mutations in the cell culture of E. coli WP2 (trp-) and S. typhimurium (his) by incubating a homogeneous cell culture with a mutagen, followed by determining the presence of mutating cell culture subpopulations, characterized in that the number of stages, the sample is examined in a liquid culture medium using a vertical beam spectrophotometer, and the mutation of the cells is determined from the change in optical density.
    to
    Ai, os
    and
    V, ti i3 and is
    tfftt t / n-z ifft.i
    Editor M. Tsitkina
     Ti i
    Fig.z
    Compiled by E.Kolmakova
    Tehred L. Oliynyk Proofreader S. Cherni
    five
    tstf,
    FIG. 2
    17
    A.
    (0: A
    tfftt t / n-z ifft.i
     Ti i
    5 fifDo
    权利要求:
    Claims (1)
    [1]
    A method for determining mutations in cell culture of E. coli WP2 (trp ~) and
    S.typhimurium (his “) by incubating a homogeneous cell culture with a mutagen and then determining the presence of mutating subpopulations of the cell culture, characterized in that, in order to simplify the method • by reducing the number of stages, the sample is examined in a liquid culture medium using a spectrophotometer with a vertical the course of the rays and the change in optical density determine the mutation of the cells.
    类似技术:
    公开号 | 公开日 | 专利标题
    Robertson et al.1998|Determination of the biomasses of small bacteria at low concentrations in a mixture of species with forward light scatter measurements by flow cytometry
    Prætorius et al.1953|Enzymatic determination of uric acid with detailed directions
    Gilliam et al.1993|A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase
    SU1442090A3|1988-11-30|Method of analyzing mutations in cultivation of cells e. coli wp2 | and s. typhimurium |
    Krueger1930|A method for the quantitative determination of bacteriophage
    US4969741A|1990-11-13|Measurement of solid particle concentration in presence of a second particle type
    Eden et al.1984|Enumeration of microorganisms by their dynamic AC conductance patterns
    Jordan et al.1978|Sulfate uptake as a measure of bacterial production 1
    Gaudy Jr et al.1964|Use of chemical oxygen demand values of bacterial cells in waste-water purification
    Samloff et al.1969|A radial diffusion assay for pepsinogen and pepsin
    Friis et al.1998|Evaluation of elemental composition of algal biomass as toxical endpoint
    Coppella et al.1990|Practical considerations in the measurement of culture fluorescence
    RU2359036C1|2009-06-20|Method of integral express-evaluation of environmental pollution
    Janaszek et al.1987|The use of the firefly bioluminescent reaction for the rapid detection and counting of mycobacterium BCG
    LAMPRECHT1976|Application of calorimetry to the evaluation of metabolic data for whole organisms
    US5051359A|1991-09-24|Method of determining the quality of a medium
    US4096037A|1978-06-20|Arginase test
    RU2050128C1|1995-12-20|Fresh water reservoir environmental condition assessment method
    Roberts Jr1977|Bioassay procedures for marine phytoplankton with special reference to chlorine
    Sinkkonen et al.1998|Chlorinated acetic and propionic acids in pine needles from industrial areas
    Chance1957|[12] Techniques for the assay of the respiratory enzymes
    SU1341607A1|1987-09-30|Method of determining activity of hydrocarbon-oxidizing bacteria
    SU1532876A1|1989-12-30|Method of determining hemolytic activity of proteolytic components of alternative route of complement
    Bowers1952|Measurement of Surface Tension of Sewage: II. Indianapolis Studies
    RU2123692C1|1998-12-20|Method of estimating quality of water
    同族专利:
    公开号 | 公开日
    EP0112888A1|1984-07-11|
    FI822473A0|1982-07-12|
    DD210076A5|1984-05-30|
    FI67404C|1986-07-28|
    IT1162893B|1987-04-01|
    NO840823L|1984-03-05|
    JPS59501294A|1984-07-26|
    IT8367732D0|1983-07-05|
    AU566150B2|1987-10-08|
    CA1204373A|1986-05-13|
    FI67404B|1984-11-30|
    FI822473L|1984-01-13|
    US4675288A|1987-06-23|
    DE3366962D1|1986-11-20|
    EP0112888B1|1986-10-15|
    WO1984000384A1|1984-02-02|
    AU1761883A|1985-02-07|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3255095A|1962-10-08|1966-06-07|Martin C Baer|Mutant detection method|
    CH573471A5|1971-02-04|1976-03-15|Bitterfeld Chemie|
    GB1358760A|1971-08-09|1974-07-03|Bitterfeld Chemie|Process for the selection of biochemically-active substances|
    US4072574A|1976-07-30|1978-02-07|The Institute For Cancer Research|System for in vitro assay for mutagenicity and/or carcinogenicity of chemicals or other exogenous agents|
    US4299915A|1977-10-17|1981-11-10|Massachusetts Institute Of Technology|Assay for mutagenesis in bacterial cells|
    US4256832A|1978-12-12|1981-03-17|Bioresearch Inc.|Carcinogen and mutagen screening method and apparatus|
    US4345026A|1981-01-12|1982-08-17|The Children's Hospital Medical Center|Mutagenicity assay|US5169755A|1986-12-30|1992-12-08|E. I. Du Pont De Nemours And Company|Process for inducing cytochrome P-450 enzymes in streptomyces bacteria and determining the mutagenicity of chemicals|
    CA1313613C|1986-12-30|1993-02-16|Fateme Sima Sariaslani|Induction of cytochrome p-450 enzymes in streptomyces bacteria|
    US5213971A|1986-12-30|1993-05-25|E. I. Du Pont De Nemours And Company|Process for inducing cytochrome P-450 enzymes in Streptomyces bacteria and determining the mutagenicity of chemicals|
    NZ223569A|1987-02-24|1990-06-26|Mobil Oil Corp|Assaying polynuclear compounds for mutagenic activity|
    US5246837A|1988-10-19|1993-09-21|Spiral System Instruments, Inc.|Processor implemented method for determining the potency of a growth affecting substance interacting with micro-organisms on the surface of microbial culture media|
    US5079145A|1988-10-21|1992-01-07|Synergen Associates, Inc.|Process for preparing microorganisms used for making phenyl acetyl carlinol |
    US4983527A|1989-05-26|1991-01-08|Arizona Board Of Regents|Oocyte test for detection of tumor promoting compounds|
    US20070237855A1|2006-04-05|2007-10-11|Cadbury Adams Usa Llc|Calcium phosphate complex in acid containing confectionery|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    FI822473A|FI67404C|1982-07-12|1982-07-12|FOERFARANDE FOER UTFOERING AV MUTAGENITETTEST|
    [返回顶部]